These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30993672)

  • 1. Trends in phenotype in the English paediatric neurofibromatosis type 2 cohort stratified by genetic severity.
    Halliday D; Emmanouil B; Vassallo G; Lascelles K; Nicholson J; Chandratre S; Anand G; Wasik M; Pretorius P; Evans DG; Parry A;
    Clin Genet; 2019 Aug; 96(2):151-162. PubMed ID: 30993672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Severity Score predicts clinical phenotype in NF2.
    Halliday D; Emmanouil B; Pretorius P; MacKeith S; Painter S; Tomkins H; Evans DG; Parry A
    J Med Genet; 2017 Oct; 54(10):657-664. PubMed ID: 28848060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted deep sequencing of DNA from multiple tissue types improves the diagnostic rate and reveals a highly diverse phenotype of mosaic neurofibromatosis type 2.
    Teranishi Y; Miyawaki S; Hongo H; Dofuku S; Okano A; Takayanagi S; Ota T; Yoshimura J; Qu W; Mitsui J; Nakatomi H; Morishita S; Tsuji S; Saito N
    J Med Genet; 2021 Oct; 58(10):701-711. PubMed ID: 33067351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution.
    Forde C; King AT; Rutherford SA; Hammerbeck-Ward C; Lloyd SK; Freeman SR; Pathmanaban ON; Stapleton E; Thomas OM; Laitt RD; Stivaros S; Kilday JP; Vassallo G; McBain C; Kerrigan S; Smith MJ; McCabe MG; Harkness EF; Evans DG
    Neuro Oncol; 2021 Jul; 23(7):1113-1124. PubMed ID: 33336705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis type 2 and related disorders.
    Halliday D; Parry A; Evans DG
    Curr Opin Oncol; 2019 Nov; 31(6):562-567. PubMed ID: 31425178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients.
    Hexter A; Jones A; Joe H; Heap L; Smith MJ; Wallace AJ; Halliday D; Parry A; Taylor A; Raymond L; Shaw A; Afridi S; Obholzer R; Axon P; King AT; ; Friedman JM; Evans DG
    J Med Genet; 2015 Oct; 52(10):699-705. PubMed ID: 26275417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of sporadic neurofibromatosis type 2 in the paediatric population.
    Anand G; Vasallo G; Spanou M; Thomas S; Pike M; Kariyawasam DS; Mehta S; Parry A; Durie-Gair J; Nicholson J; Lascelles K; Everett V; Gibbon FM; Jarvis N; Elston J; Evans DG; Halliday D
    Arch Dis Child; 2018 May; 103(5):463-469. PubMed ID: 29535107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paediatric presentation of type 2 neurofibromatosis.
    Evans DG; Birch JM; Ramsden RT
    Arch Dis Child; 1999 Dec; 81(6):496-9. PubMed ID: 10569966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis type 2 (NF2): diagnosis and management.
    Lloyd SK; Evans DG
    Handb Clin Neurol; 2013; 115():957-67. PubMed ID: 23931824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.
    Baser ME; Kuramoto L; Woods R; Joe H; Friedman JM; Wallace AJ; Ramsden RT; Olschwang S; Bijlsma E; Kalamarides M; Papi L; Kato R; Carroll J; Lázaro C; Joncourt F; Parry DM; Rouleau GA; Evans DG
    J Med Genet; 2005 Jul; 42(7):540-6. PubMed ID: 15994874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.
    Mohyuddin A; Neary WJ; Wallace A; Wu CL; Purcell S; Reid H; Ramsden RT; Read A; Black G; Evans DG
    J Med Genet; 2002 May; 39(5):315-22. PubMed ID: 12011146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of stereotactic radiosurgery for intracranial schwannoma in neurofibromatosis type 2: a genetic analysis perspective.
    Shinya Y; Teranishi Y; Hasegawa H; Miyawaki S; Sugiyama T; Shin M; Kawashima M; Umekawa M; Katano A; Nakatomi H; Saito N
    J Neurooncol; 2024 Jan; 166(1):185-194. PubMed ID: 38151698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Type 2 neurofibromatosis: intergenerational differences in genetic and clinical expression].
    Drouet A; Le Moigne F; Salamé D; Quesnel L; Motolese C; des Portes V; Guilloton L; Pinson S
    Arch Pediatr; 2014 Nov; 21(11):1233-40. PubMed ID: 25439059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies.
    Ruggieri M; Praticò AD; Serra A; Maiolino L; Cocuzza S; Di Mauro P; Licciardello L; Milone P; Privitera G; Belfiore G; Di Pietro M; Di Raimondo F; Romano A; Chiarenza A; Muglia M; Polizzi A; Evans DG
    Acta Otorhinolaryngol Ital; 2016 Oct; 36(5):345-367. PubMed ID: 27958595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
    Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
    J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of hearing loss in neurofibromatosis type 2 according to genetic severity.
    Emmanouil B; Houston R; May A; Ramsden JD; Hanemann CO; Halliday D; Parry A; Mackeith S
    Laryngoscope; 2019 Apr; 129(4):974-980. PubMed ID: 30456886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
    Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
    Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromatosis type 2.
    Evans DG
    Handb Clin Neurol; 2015; 132():87-96. PubMed ID: 26564072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromatosis Type 2-Related Eye Disease Correlated With Genetic Severity Type.
    Painter SL; Sipkova Z; Emmanouil B; Halliday D; Parry A; Elston JS
    J Neuroophthalmol; 2019 Mar; 39(1):44-49. PubMed ID: 29923868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis and management of neurofibromatosis 2 in childhood.
    MacCollin M; Mautner VF
    Semin Pediatr Neurol; 1998 Dec; 5(4):243-52. PubMed ID: 9874852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.